236 related articles for article (PubMed ID: 33352232)
21. Physicochemical Profiling of Baicalin Along with the Development and Characterization of Cyclodextrin Inclusion Complexes.
Jakab G; Bogdán D; Mazák K; Deme R; Mucsi Z; Mándity IM; Noszál B; Kállai-Szabó N; Antal I
AAPS PharmSciTech; 2019 Sep; 20(8):314. PubMed ID: 31529175
[TBL] [Abstract][Full Text] [Related]
22. Baicalin relieves
Zhang H; Li X; Wang J; Cheng Q; Shang Y; Wang G
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109422
[No Abstract] [Full Text] [Related]
23. Exploring the molecular targets of dietary flavonoid fisetin in cancer.
Syed DN; Adhami VM; Khan N; Khan MI; Mukhtar H
Semin Cancer Biol; 2016 Oct; 40-41():130-140. PubMed ID: 27163728
[TBL] [Abstract][Full Text] [Related]
24. Baicalin Induces Apoptotic Death of Human Chondrosarcoma Cells through Mitochondrial Dysfunction and Downregulation of the PI3K/Akt/mTOR Pathway.
Zhu M; Ying J; Lin C; Wang Y; Huang K; Zhou Y; Teng H
Planta Med; 2019 Mar; 85(5):360-369. PubMed ID: 30469147
[TBL] [Abstract][Full Text] [Related]
25. Baicalin Inhibits Human Cervical Cancer Cells by Suppressing Protein Kinase C/Signal Transducer and Activator of Transcription (PKC/STAT3) Signaling Pathway.
Wang Q; Xu H; Zhao X
Med Sci Monit; 2018 Apr; 24():1955-1961. PubMed ID: 29610452
[TBL] [Abstract][Full Text] [Related]
26. Induction of apoptosis in prostate cancer cell lines by a flavonoid, baicalin.
Chan FL; Choi HL; Chen ZY; Chan PS; Huang Y
Cancer Lett; 2000 Nov; 160(2):219-28. PubMed ID: 11053652
[TBL] [Abstract][Full Text] [Related]
27. Xanthohumol for Human Malignancies: Chemistry, Pharmacokinetics and Molecular Targets.
Harish V; Haque E; Śmiech M; Taniguchi H; Jamieson S; Tewari D; Bishayee A
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923053
[TBL] [Abstract][Full Text] [Related]
28. Baicalin inhibits breast cancer development via inhibiting IĸB kinase activation in vitro and in vivo.
Gao Y; Liu H; Wang H; Hu H; He H; Gu N; Han X; Guo Q; Liu D; Cui S; Shao H; Jin C; Wu Q
Int J Oncol; 2018 Dec; 53(6):2727-2736. PubMed ID: 30320365
[TBL] [Abstract][Full Text] [Related]
29. Baicalin, the major component of traditional Chinese medicine Scutellaria baicalensis induces colon cancer cell apoptosis through inhibition of oncomiRNAs.
Tao Y; Zhan S; Wang Y; Zhou G; Liang H; Chen X; Shen H
Sci Rep; 2018 Sep; 8(1):14477. PubMed ID: 30262902
[TBL] [Abstract][Full Text] [Related]
30. Silymarin antiproliferative and apoptotic effects: Insights into its clinical impact in various types of cancer.
Hosseinabadi T; Lorigooini Z; Tabarzad M; Salehi B; Rodrigues CF; Martins N; Sharifi-Rad J
Phytother Res; 2019 Nov; 33(11):2849-2861. PubMed ID: 31407422
[TBL] [Abstract][Full Text] [Related]
31. Luteolin, a flavonoid with potential for cancer prevention and therapy.
Lin Y; Shi R; Wang X; Shen HM
Curr Cancer Drug Targets; 2008 Nov; 8(7):634-46. PubMed ID: 18991571
[TBL] [Abstract][Full Text] [Related]
32. Myricetin: A Significant Emphasis on Its Anticancer Potential via the Modulation of Inflammation and Signal Transduction Pathways.
Rahmani AH; Almatroudi A; Allemailem KS; Alwanian WM; Alharbi BF; Alrumaihi F; Khan AA; Almatroodi SA
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298616
[TBL] [Abstract][Full Text] [Related]
33. A review on the chemotherapeutic potential of fisetin: In vitro evidences.
Sundarraj K; Raghunath A; Perumal E
Biomed Pharmacother; 2018 Jan; 97():928-940. PubMed ID: 29136771
[TBL] [Abstract][Full Text] [Related]
34. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis.
Yu Z; Zhan C; Du H; Zhang L; Liang C; Zhang L
Mol Cell Biochem; 2020 Jun; 469(1-2):169-178. PubMed ID: 32385718
[TBL] [Abstract][Full Text] [Related]
35. Anticancer Properties of Baicalin against Breast Cancer and other Gynecological Cancers: Therapeutic Opportunities based on Underlying Mechanisms.
Pourhanifeh MH; Farrokhi-Kebria H; Mostanadi P; Farkhondeh T; Samarghandian S
Curr Mol Pharmacol; 2024; 17():e18761429263063. PubMed ID: 38284731
[TBL] [Abstract][Full Text] [Related]
36. Baicalin, an emerging multi-therapeutic agent: pharmacodynamics, pharmacokinetics, and considerations from drug development perspectives.
Srinivas NR
Xenobiotica; 2010 May; 40(5):357-67. PubMed ID: 20230189
[TBL] [Abstract][Full Text] [Related]
37. Effects of the flavonoid baicalin and its metabolite baicalein on androgen receptor expression, cell cycle progression and apoptosis of prostate cancer cell lines.
Chen S; Ruan Q; Bedner E; Deptala A; Wang X; Hsieh TC; Traganos F; Darzynkiewicz Z
Cell Prolif; 2001 Oct; 34(5):293-304. PubMed ID: 11591177
[TBL] [Abstract][Full Text] [Related]
38. Current methodologies to refine bioavailability, delivery, and therapeutic efficacy of plant flavonoids in cancer treatment.
Vazhappilly CG; Amararathna M; Cyril AC; Linger R; Matar R; Merheb M; Ramadan WS; Radhakrishnan R; Rupasinghe HPV
J Nutr Biochem; 2021 Aug; 94():108623. PubMed ID: 33705948
[TBL] [Abstract][Full Text] [Related]
39. Systematic Understanding of the Mechanism of Baicalin against Ischemic Stroke through a Network Pharmacology Approach.
Xu T; Ma C; Fan S; Deng N; Lian Y; Tan L; Du W; Zhang S; Liu S; Ren B; Li Z; Wang Q; Wang X; Cheng F
Evid Based Complement Alternat Med; 2018; 2018():2582843. PubMed ID: 30647760
[TBL] [Abstract][Full Text] [Related]
40. In vitro studies of baicalin alone or in combination with Salvia miltiorrhiza extract as a potential anti-cancer agent.
Franek KJ; Zhou Z; Zhang WD; Chen WY
Int J Oncol; 2005 Jan; 26(1):217-24. PubMed ID: 15586243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
